XML 40 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2013
FAIR VALUE MEASUREMENTS  
Schedule of available-for-sale securities and derivative financial instruments measured at fair value

The fair value of the Company's available-for-sale securities and derivative financial instruments was determined using the following inputs (amounts in thousands):

 
   
   
  Fair Value
Measurements
Using Fair Value
Hierarchy on a
Recurring Basis
 
 
  Year Ended
December 31,
  Carrying and
Fair Value
 
 
  Level 1   Level 2  

Financial assets:

                         

Available-for-sale securities:

                         

Equity securities

    2013   $ 282   $ 282   $  

 

    2012     278     278      

Derivative financial instruments:

                         

Interest rate swaps

    2013     265         265  

 

    2012              

Financial liabilities:

                         

Derivative financial instruments:

                         

Interest rate swaps

    2013     774         774  

 

    2012     1,470         1,470  
Schedule of effect of derivative financial instruments on statement of income

The following table presents the effect of the Company's derivative financial instruments on the statement of income for the periods presented (amounts in thousands):

 
  Years Ended December 31,  
 
  2013   2012   2011  

Consolidated

                   

Amount of (loss) recognized on derivatives in Other comprehensive (loss)

  $ (1 ) $ (1,051 ) $ (1,098 )

Amount of (loss) reclassification from Accumulated other comprehensive (loss) into Interest expense

    (962 )   (504 )   (351 )

Joint Ventures (Company's share)

   
 
   
 
   
 
 

Amount of gain (loss) recognized on derivative in Other comprehensive (loss)

  $ 21   $ (79 ) $ (225 )

Amount of (loss) reclassification from Accumulated Other comprehensive (loss) into Equity in earnings of unconsolidated joint ventures

    (55 )   (56 )   (43 )